Immunogenicity of an autogenous Streptococcus suis bacterin in preparturient sows and their piglets in relation to protection after weaning

Clinical and Vaccine Immunology

Volumn 17, Issue 10, 2010, Pages 1589-1597

  Baums, Christoph Georg ^a   Brüggemann, Christian ^a   Kock, Christoph ^a   Beineke, Andreas ^a   Waldmann, Karl Heinz ^a   Valentin Weigand, Peter ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIN; IMMUNOGLOBULIN G;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLOSTRUM; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNOGENICITY; NONHUMAN; PIGLET; PRIORITY JOURNAL; SOW (SWINE); STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; STREPTOCOCCUS SUIS INFECTION; VACCINATION; WEANING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BLOOD; COLOSTRUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; OPSONIN PROTEINS; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SWINE; SWINE DISEASES;

EID: 77957869917     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00159-10     Document Type: Article

References (25)

1. Amass, S. F., G. W. Stevenson, B. D. Vyverberg, T. W. Huxford, K. E. Knox, and L. A. Grote. 2000. Administration of a homologous bacterin to sows prefarrowing provided partial protection against streptococcosis in their weaned pigs. Swine Health Prod. 8:217-219.
2. Baums, C. G., U. Kaim, M. Fulde, G. Ramachandran, R. Goethe, and P. Valentin-Weigand. 2006. Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infect. Immun. 74:6154-6162.
3. Baums, C. G., C. Kock, A. Beineke, K. Bennecke, R. Goethe, C. Schröder, K. H. Waldmann, and P. Valentin-Weigand. 2009. Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9. Clin. Vaccine Immunol. 16:200-208.
4. Baums, C. G., and P. Valentin-Weigand. 2009. Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development. Anim. Health Res. Rev. 10:65-83.
5. Baums, C. G., G. J. Verkühlen, T. Rehm, L. M. Silva, M. Beyerbach, K. Pohlmeyer, and P. Valentin-Weigand. 2007. Prevalence of Streptococcus suis genotypes in wild boars of Northwestern Germany. Appl. Environ. Microbiol. 73:711-717.
6. Beineke, A., K. Bennecke, C. Neis, C. Schröder, K. H. Waldmann, W. Baumgartner, P. Valentin-Weigand, and C. G. Baums. 2008. Comparative evaluation of virulence and pathology of Streptococcus suis serotypes 2 and 9 in experimentally infected growers. Vet. Microbiol. 128:423-430.
7. Butler, J. E., N. Wertz, N. Deschacht, and I. Kacskovics. 2009. Porcine IgG: structure, genetics, and evolution. Immunogenetics 61:209-230.
8. Butler, J. E., Y. Zhao, M. Sinkora, N. Wertz, and I. Kacskovics. 2009. Immunoglobulins, antibody repertoire and B cell development. Dev. Comp. Immunol. 33:321-333.
9. Gottschalk, M., M. Segura, and J. Xu. 2007. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim. Health Res. Rev. 8:29-45.
10. Haesebrouck, F., F. Pasmans, K. Chiers, D. Maes, R. Ducatelle, and A. Decostere. 2004. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet. Microbiol. 100:255-268. (Pubitemid 38625696)
11. Higgins, R., and M. Gottschalk. 2005. Streptococcal diseases, p. 769-783. In B. Straw, S. D. Allaire, W. Mengeling, and D. Taylor (ed.), Diseases of swine. Iowa State University, Ames, IA.
12. Kacskovics, I., J. Sun, and J. E. Butler. 1994. Five putative subclasses of swine IgG identified from the cDNA sequences of a single animal. J. Immunol. 153:3565-3573.
13. Kock, C., A. Beineke, M. Seitz, M. Ganter, K. H. Waldmann, P. Valentin-Weigand, and C. G. Baums. 2009. Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection. Vet. Immunol. Immunopathol. 132:135-145.
14. Li, Y., M. Gottschalk, M. Esgleas, S. Lacouture, J. D. Dubreuil, P. Willson, and J. Harel. 2007. Immunization with recombinant Sao protein confers protection against Streptococcus suis infection. Clin. Vaccine Immunol. 14:937-943.
15. Li, Y., G. Martinez, M. Gottschalk, S. Lacouture, P. Willson, J. D. Dubreuil, M. Jacques, and J. Harel. 2006. Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs. Infect. Immun. 74:305-312.
16. Metzger, J. J., and M. Fougereau. 1967. Characterization of two subclasses of gamma G immunoglobulin in swine. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 265:724-727.
17. Nguyen, T. V., L. Yuan, M. S. Azevedo, K. I. Jeong, A. M. Gonzalez, C. Iosef, K. Lovgren-Bengtsson, B. Morein, P. Lewis, and L. J. Saif. 2006. High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen. Clin. Vaccine Immunol. 13:475-485.
18. Nguyen, T. V., L. Yuan, M. S. P. Azevado, K. I. Jeong, A. M. Gonzalez, C. Iosef, K. Lovgren-Bengtsson, B. Morein, P. Lewis, and L. J. Saif. 2006. Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. Vaccine 24:2302-2316.
19. Romero-Steiner, S., D. Libutti, L. B. Pais, J. Dykes, P. Anderson, J. C. Whitin, H. L. Keyserling, and G. M. Carlone. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
20. Silva, L. M., C. G. Baums, T. Rehm, H. J. Wisselink, R. Goethe, and P. Valentin-Weigand. 2006. Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Vet. Microbiol. 115:117-127.
21. Smith, H. E., M. Damman, J. van der Velde, F. Wagenaar, H. J. Wisselink, N. Stockhofe-Zurwieden, and M. A. Smits. 1999. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. Immun. 67:1750-1756.
22. Smith, H. E., F. H. Reek, U. Vecht, A. L. J. Gielkens, and M. A. Smits. 1993. Repeats in an extracellular protein of weakly pathogenic strains of Streptococcus suis type 2 are absent in pathogenic strains. Infect. Immun. 61:3318-3326.
23. Vecht, U., H. J. Wisselink, J. E. van Dijk, and H. E. Smith. 1992. Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect. Immun. 60:550-556.
24. Wisselink, H. J., H. E. Smith, N. Stockhofe-Zurwieden, K. Peperkamp, and U. Vecht. 2000. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet. Microbiol. 74:237-248.
25. Wisselink, H. J., U. Vecht, N. Stockhofe-Zurwieden, and H. E. Smith. 2001. Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet. Rec. 148:473-477.